Evolva, IFF progress in natural vanillin production

International Flavors and Fragrances and Evolva Holdings have entered the pre-production phase for natural vanillin for global food and flavor markets.The partnership between IFF and Evolva was signed on January 2011

vanilla-beans-flower2-edited

Evolva, IFF to produce natural vanillin

International Flavors and Fragrances (IFF), a leading global creator of flavors and fragrances for consumer products and Evolva Holding SA, Reinach, Switzerland, a biosynthesis technology expert, have entered into pre-production phase to develop and scale-up, via a third party, natural vanillin for commercial application through a cost-effective, natural and sustainable route.

The two companies are working to confirm scalability and yield targets through a yeast-based fermentation route during the pre-manufacturing phase. This announcement follows the one in June 2012 where Evolva confirmed the achievement of the first milestone in this collaboration. The partnership between IFF and Evolva was originally signed and announced in January 2011.

Mr Mark Dewis, vice president, R&D, IFF commented that, "We are very excited about our collaboration with Evolva, an expert in the biotechnology field, on the development of a key flavoring ingredient that is used in IFF flavors and the potential to be able to deliver a market product with industry significance that is operationally scalable. If the scale up is successful this innovative solution should provide a sustainable source for what has been a volatile raw material and should provide IFF customers with unique products."

Dr Panchapagesa Murali, CEO, Evolva Biotech said, "We have been working with IFF for the last two years and are convinced that they are ideally positioned to deliver on the sales and marketing of our vanillin product. Teaming up with a recognised industry leader such as IFF provides clear validation of the potential of our technology and products. We strongly believe that fermentation as an innovative and sustainable way to produce vanillin is a very attractive alternative to the traditional production routes."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

Ancillare Announces New Vice President of Asia-Pacific

Tuesday, 6 Dec 2016   |   Ancillare, LP

Business Wire India Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain

ABOUND Data Presented at the World Conference on Lung Cancer Further Explores

Tuesday, 6 Dec 2016   |   Celgene Corporation

Business Wire India Celgene Corporation (NASDAQ:CELG) today announced interim results from the ABOUND

U.S. FDA approves Jardiance® (empagliflozin) tablets to reduce the risk

Tuesday, 6 Dec 2016   |   Boehringer Ingelheim

Business Wire India The U.S. Food and Drug Administration (FDA) approved a new indication for Jardiance®

BusinessWire India.com - Pharmaceutical

Bwi-logo

ABOUND Data Presented at the World Conference on Lung Cancer Further Explores

Tuesday, 6 Dec 2016   |   Celgene Corporation

Business Wire India Celgene Corporation (NASDAQ:CELG) today announced interim results from the ABOUND

Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat

Tuesday, 6 Dec 2016   |   AstraZeneca

Business Wire India AstraZeneca and its haematology Centre of Excellence, Acerta Pharma, announced preliminary

New Data Show High Adherence Rates with Pradaxa® (dabigatran etexilate)

Monday, 5 Dec 2016   |   Boehringer Ingelheim

Business Wire India Boehringer Ingelheim today announced results from a new analysis of the GLORIA™-AF

BusinessWire India.com - Medical Devices

Bwi-logo

Worldwide Achievers Felicitated the Winners of International Healthcare

Monday, 5 Dec 2016   |   Worldwide Achievers Pvt. Ltd

Business Wire India Worldwide Achievers has initiated the International Healthcare Summit & Awards 2016 association with

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X